This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Schisandra Chinensis
Adaptogenic berry from Chinese, Russian, Korean traditional medicine — the "five-flavor berry" (sweet, sour, salty, bitter, pungent).
Aliases (6)
Overview
What is Schisandra Chinensis?
Schisandra chinensis is a traditional Chinese medicinal berry classified as an adaptogen, valued for its lignan-rich extract (schisandrins A-C, schisantherin, gomisins). It is used to improve stress resilience, liver detoxification, mental performance, and physical endurance.
Key Benefits
Increases stress tolerance and reduces fatigue, supports hepatic detoxification and protects against oxidative liver injury, sharpens focus and reaction time, and shows mild adaptogenic-anxiolytic effects without sedation.
Mechanism of Action
Schisandra lignans activate the Nrf2/ARE antioxidant pathway and induce hepatic Phase I/II detox enzymes (cytochrome P450 and glutathione-S-transferases). They also modulate the HPA axis (blunting excessive cortisol responses to stress) and exert mild monoamine-oxidase inhibition contributing to cognitive effects.
Peptide Interactions
(in the canonical stack): Classical Russian adaptogen pairing
Three-adaptogen Russian "ADAPT-232" combination
(in the canonical stack): Compound liver/glutathione support
Independent hepatoprotection, complementary mechanism
Statins, tacrolimus, cyclosporine, oral contraceptives, certain antivirals, midazolam, some ED drugs
Compound induction, hard to predict net effect
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety
- Common (>10%): Mild GI symptoms — heartburn, acid reflux, mild nausea
- Less common (1-10%): Restlessness, mild headache, decreased appetite
- Rare-serious (<1%): Allergic reactions; theoretical hepatotoxicity at very high doses (paradoxical given hepatoprotective use)
- Specific watch periods: GI tolerance in first 2 weeks
- Major drug-interaction warning: CYP3A4 induction — discontinue if starting any new prescription, check substrate list
References
Panossian & Wikman 2008 — adaptogens including schisandra mechanism review (Phytomedicine)
Aslanyan et al. 2010 — ADAPT-232 cognitive RCT (Phytomedicine)
Mai et al. 2004 — schisandra-midazolam CYP3A4 interaction (Eur J Clin Pharmacol)
Szopa et al. 2017 — schisandra lignans pharmacology review (Phytochem Rev)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.